TCL Archive ICCCR Loses Support Of French, DeVita Resigns As President, Fischinger To Take Over July 17, 1992
TCL Archive Community Cancer Control Program Survives Schmidt Criticism; NCAB Votes To Continue October 17, 1975
TCL Archive Also Von Eschenbach role in industry program raises new concerns of conflict of interest. November 23, 2005
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
